Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs Touch Medical Media Services 34:17 5 months ago 99 Скачать Далее
Are You Prepared for the New Wave of ADCs in NSCLC? Targeting HER2, HER3, TROP2, and Others PeerView Oncology 56:23 1 year ago 5 278 Скачать Далее
Dr. Aggarwal on Emerging Treatment Approaches in ALK+ NSCLC OncLive 1:05 4 years ago 112 Скачать Далее
Locally advanced NSCLC: Combination therapy with targeted and immunotherapy agents HMP Education 25:26 6 years ago 1 235 Скачать Далее
Addressing Key Targets in Advanced NSCLC: HER2-, HER3-, and TROP2-Targeted Therapies PeerView Oncology 58:27 2 years ago 1 355 Скачать Далее
Role of Maintenance Therapy in Advanced NSCLC - Dr. Corey Langer HMP Education 21:02 11 years ago 184 Скачать Далее
The evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma Touch Medical Media Services 31:39 2 years ago 220 Скачать Далее
Advanced NSCLC: Refining Clinical Pathways in the Rapidly Evolving Therapeutic Landscape HMP Education 44:56 3 years ago 3 961 Скачать Далее
Navigating the complexities of the NSCLC treatment pathway: A focus on antibody-drug conjugates Touch Medical Media Services 32:14 1 year ago 47 Скачать Далее
Conversations in Advanced NSCLC - Rationale for ADCs Practice Point Communications 15:37 7 months ago 14 Скачать Далее
The Role of Antibody Drug Conjugates in Advanced Non-Small Cell Lung Cancer CME Outfitters 1:26:11 3 years ago 333 Скачать Далее
